AU772188B2 - Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use - Google Patents
Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use Download PDFInfo
- Publication number
- AU772188B2 AU772188B2 AU19152/00A AU1915200A AU772188B2 AU 772188 B2 AU772188 B2 AU 772188B2 AU 19152/00 A AU19152/00 A AU 19152/00A AU 1915200 A AU1915200 A AU 1915200A AU 772188 B2 AU772188 B2 AU 772188B2
- Authority
- AU
- Australia
- Prior art keywords
- nitric oxide
- patient
- compound
- group
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CCN(C*(C)=C)Cc1cc(BCCCNC(COC(*Oc2ccccc2)=O)=O)ccc1 Chemical compound CCN(C*(C)=C)Cc1cc(BCCCNC(COC(*Oc2ccccc2)=O)=O)ccc1 0.000 description 7
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004202027A AU2004202027B2 (en) | 1998-11-17 | 2004-05-12 | Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10887798P | 1998-11-17 | 1998-11-17 | |
US60/108877 | 1998-11-17 | ||
US14083999P | 1999-06-28 | 1999-06-28 | |
US60/140839 | 1999-06-28 | ||
PCT/US1999/027207 WO2000028988A1 (fr) | 1998-11-17 | 1999-11-17 | Composes et compositions antagonistes de recepteurs de h2 nitroses et nitrosyles et procedes d'utilisation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004202027A Division AU2004202027B2 (en) | 1998-11-17 | 2004-05-12 | Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1915200A AU1915200A (en) | 2000-06-05 |
AU772188B2 true AU772188B2 (en) | 2004-04-08 |
Family
ID=26806378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19152/00A Ceased AU772188B2 (en) | 1998-11-17 | 1999-11-17 | Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
Country Status (6)
Country | Link |
---|---|
US (4) | US6552047B2 (fr) |
EP (1) | EP1140066A4 (fr) |
JP (1) | JP2002529503A (fr) |
AU (1) | AU772188B2 (fr) |
CA (1) | CA2349575A1 (fr) |
WO (1) | WO2000028988A1 (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141244B1 (en) * | 1992-03-02 | 2006-11-28 | Chiron Srl | Helicobacter pylori proteins useful for vaccines and diagnostics |
CA2194237A1 (fr) * | 1994-07-01 | 1996-01-18 | Dermot Kelleher | Preparation a base de proteine antigene d'helicobacter pylori et dosage immunologique |
DK0909323T3 (da) * | 1996-01-04 | 2007-05-21 | Novartis Vaccines & Diagnostic | Helicobacter pylori-bakterioferritin |
US6821285B2 (en) | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US7846180B2 (en) | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
US8287554B2 (en) * | 1999-06-22 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Method and devices for tissue reconfiguration |
US6663639B1 (en) * | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US20050175629A1 (en) * | 2001-08-31 | 2005-08-11 | Giuseppe Del Giudice | Helicobacter pylori vaccination |
AU2006252204B2 (en) * | 2001-12-06 | 2010-07-08 | Duke University | Prevention of Flap Necrosis in Plastic Surgery |
EP1497268A4 (fr) * | 2002-04-05 | 2006-01-18 | Nitromed Inc | Donneurs de monoxyde d'azote, compositions et procedes d'utilisation, applications correspondantes |
US20040038947A1 (en) | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
US6936639B2 (en) | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
US20050113409A1 (en) * | 2003-09-03 | 2005-05-26 | Pharmacia Corporation | Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith |
WO2005105765A1 (fr) * | 2004-05-05 | 2005-11-10 | Renopharm Ltd. | Donneurs d'oxyde nitrique et utilisations de ceux-ci |
US7968575B2 (en) * | 2004-05-05 | 2011-06-28 | Renopharm Ltd. | Nitric oxide donors and uses thereof |
US8134010B2 (en) * | 2004-05-05 | 2012-03-13 | Renopharm Ltd. | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof |
AU2005304770A1 (en) * | 2004-11-08 | 2006-05-18 | Nicox S.A. | Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders |
JP2008520578A (ja) * | 2004-11-15 | 2008-06-19 | ニトロメッド インコーポレーティッド | 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法 |
WO2007086884A2 (fr) * | 2005-02-16 | 2007-08-02 | Nitromed, Inc. | Sels donneurs d’oxyde nitrique organique de composes antimicrobiens et composes et procedes d’utilisation |
US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
US20080020040A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Unit dose form for administration of ibuprofen |
NZ565846A (en) * | 2005-07-18 | 2011-12-22 | Horizon Therapeutics Inc | Medicaments containing famotidine and ibuprofen and administration of same |
US20090018091A1 (en) | 2005-08-02 | 2009-01-15 | Nitromed, Inc. | Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use |
WO2007126609A1 (fr) | 2006-03-29 | 2007-11-08 | Nitromed, Inc. | Prostaglandines amplificatrices d'oxyde nitrique, compositions et méthodes d'utilisation |
US8067033B2 (en) * | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
US20100297224A1 (en) * | 2006-08-31 | 2010-11-25 | Horizon Therapeutics, Inc. | NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use |
US7801502B2 (en) * | 2006-12-18 | 2010-09-21 | Aai Corporation | Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
WO2009089134A1 (fr) | 2008-01-04 | 2009-07-16 | Src, Inc. | Méthodes de mesure de la réponse d'un patient à l'administration d'un médicament ou de ses compositions |
US8058296B2 (en) * | 2008-11-25 | 2011-11-15 | Richard Tokunaga | Treatment and prevention of deleterious effects associated with alcohol consumption |
CN102753519B (zh) | 2009-12-07 | 2015-08-05 | 约翰斯霍普金斯大学 | 二酰基化的羟基胺衍生物 |
US8409628B2 (en) | 2010-02-04 | 2013-04-02 | Penguin IP Holdings, Inc. | Methods and compositions for oxygenation of skin to treat skin disorders |
US8900601B2 (en) | 2010-03-31 | 2014-12-02 | Jennifer Bartels | Permeable mixtures, methods and compositions for the skin |
WO2015009882A2 (fr) * | 2013-07-18 | 2015-01-22 | The Hamner Institutes | Dérivés cyano et leurs utilisations |
IL299845A (en) | 2020-07-15 | 2023-03-01 | Schabar Res Associates Llc | Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn |
US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1338169A (en) | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
US5102902A (en) | 1973-06-18 | 1992-04-07 | Mercer James B | Reagents and method for therapeutic treatment of multiple sclerosis |
US4279906A (en) | 1977-11-10 | 1981-07-21 | Nasa | Indomethacin-antihistamine combination for gastric ulceration control |
JPS54106468A (en) * | 1978-02-10 | 1979-08-21 | Mitsubishi Yuka Yakuhin Kk | Imidazole derivative and its manufacture |
FR2446829A1 (fr) * | 1978-11-16 | 1980-08-14 | Glaxo Group Ltd | Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant |
JPS6056143B2 (ja) * | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
US4293557A (en) * | 1979-07-03 | 1981-10-06 | Teikoku Hormone Mfg. Co., Ltd. | Antiulcer phenoxypropylamine derivatives |
US4375547A (en) | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
CA1254212A (fr) * | 1982-11-12 | 1989-05-16 | Shiro Hirai | Amines derives, leur sels, procede de preparation et agent anti-ulcereux les contenant |
US4742083A (en) | 1983-08-24 | 1988-05-03 | Lever Brothers Company | Method of relieving pain and inflammatory conditions employing substituted salicylamides |
IT1196133B (it) * | 1984-06-06 | 1988-11-10 | Ausonia Farma Srl | Derivati furanici con attivita' antiulcera |
NZ215069A (en) | 1985-03-01 | 1988-06-30 | Reckitt & Colmann Prod Ltd | Pharmaceutical composition with histamine h 2 -receptor antagonist |
HU194845B (en) * | 1985-09-11 | 1988-03-28 | Richter Gedeon Vegyeszet | Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin |
EP0224612A1 (fr) | 1985-12-05 | 1987-06-10 | HEUMANN PHARMA GMBH & CO | Procédé de préparation de N-cyano-N'-méthyl-N''[(méthyl-5-imidazolyl-4)méthylthio)-2-éthyl]guanidine |
US5037815A (en) * | 1986-03-04 | 1991-08-06 | Bristol-Myers Squibb Co. | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers |
IL85472A (en) | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
EP0282132B1 (fr) | 1987-03-09 | 1992-09-30 | The Procter & Gamble Company | Compositions et leur utilisation dans le traitement d'affections gastrointestinales |
ATE86619T1 (de) | 1987-04-06 | 1993-03-15 | Heumann Pharma Gmbh & Co | Verfahren zur herstellung von nitroethenderivaten. |
KR960011236B1 (ko) | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
JP2733849B2 (ja) | 1987-10-12 | 1998-03-30 | ボロディー,ソーマス・ユリウス | 胃腸障害治療のための改良された方法 |
US4900741A (en) | 1988-06-30 | 1990-02-13 | Biomed Researchy Consultants, Ltd. | Combined cimetidine-pirensepine formulation for treating peptic ulcers and erosions |
CS274996B2 (en) | 1989-05-24 | 1991-12-17 | Ustav Ex Farmakol | Drugs for stomach and duodenum ulcerous disease |
FR2655266B1 (fr) | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
GB9127150D0 (en) * | 1991-12-20 | 1992-02-19 | Smithkline Beecham Plc | Novel treatment |
EP0663839A4 (fr) | 1992-09-29 | 1998-06-03 | Merck & Co Inc | Combinaisons d'ibuprofene-antihistaminique anti-h 2?. |
WO1995010281A1 (fr) | 1993-10-13 | 1995-04-20 | Merck & Co., Inc. | Traitement associe pour l'infection par le vih |
US5541212A (en) * | 1994-01-10 | 1996-07-30 | Metatron, Inc. | Use of cimetidine for the control of retrovirus infections |
US5703073A (en) * | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
CA2176414A1 (fr) | 1995-05-18 | 1996-11-19 | S. David Kimball | Promedicaments a base de guanidine et d'amidine acylees |
SE9600791L (sv) | 1996-02-27 | 1997-08-28 | Holdingbolaget Vid Goeteborgs | Metod för eradikering av Helicobacter pylori infektion |
WO1997033576A1 (fr) | 1996-03-12 | 1997-09-18 | Bristol-Myers Squibb Company | Bioprecurseurs de carbamyl guanidine et d'amidine |
IT1298338B1 (it) | 1998-03-05 | 1999-12-20 | Nicox Sa | Composizioni farmaceutiche per l'ulcera |
IT1299198B1 (it) | 1998-03-05 | 2000-02-29 | Nicox Sa | Sali nitrati di farmaci antiulcera |
US7189750B2 (en) * | 2004-05-05 | 2007-03-13 | Renopharm Ltd. | Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof |
-
1999
- 1999-11-17 EP EP99962784A patent/EP1140066A4/fr not_active Withdrawn
- 1999-11-17 WO PCT/US1999/027207 patent/WO2000028988A1/fr active IP Right Grant
- 1999-11-17 US US09/441,891 patent/US6552047B2/en not_active Expired - Fee Related
- 1999-11-17 CA CA002349575A patent/CA2349575A1/fr not_active Abandoned
- 1999-11-17 JP JP2000582035A patent/JP2002529503A/ja active Pending
- 1999-11-17 AU AU19152/00A patent/AU772188B2/en not_active Ceased
-
2002
- 2002-10-29 US US10/282,071 patent/US6936627B2/en not_active Expired - Fee Related
-
2005
- 2005-07-14 US US11/180,790 patent/US7129251B2/en not_active Expired - Fee Related
-
2006
- 2006-09-11 US US11/518,231 patent/US7256205B2/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
ANAL. CHIM. ACTA, 1996, 332, 39-48 * |
MUTATION RESEARCH, 1989, 227, 13-16 * |
Also Published As
Publication number | Publication date |
---|---|
US7256205B2 (en) | 2007-08-14 |
US20020077343A1 (en) | 2002-06-20 |
US20030060492A1 (en) | 2003-03-27 |
AU1915200A (en) | 2000-06-05 |
US6936627B2 (en) | 2005-08-30 |
US7129251B2 (en) | 2006-10-31 |
US6552047B2 (en) | 2003-04-22 |
CA2349575A1 (fr) | 2000-05-25 |
JP2002529503A (ja) | 2002-09-10 |
US20050250758A1 (en) | 2005-11-10 |
WO2000028988A1 (fr) | 2000-05-25 |
EP1140066A1 (fr) | 2001-10-10 |
EP1140066A4 (fr) | 2005-11-09 |
US20070004788A1 (en) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU772188B2 (en) | Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use | |
US6593347B2 (en) | Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use | |
US20070179150A1 (en) | Nitrosated proton pump inhibitors, compositions and methods of use | |
AU2005202553A1 (en) | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use | |
US20050038029A1 (en) | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs | |
US7332505B2 (en) | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use | |
AU5701699A (en) | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use | |
US20050187222A1 (en) | Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds | |
US6469065B1 (en) | Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use | |
AU2004202027B2 (en) | Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use | |
AU2004200091B2 (en) | Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use | |
AU2004201585B2 (en) | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |